Variant report
Variant | nsv562605 |
---|---|
Chromosome Location | chr13:85858193-85865524 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7320578 | chr13:85858193-85858194 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs558273474 | chr13:85862203-85862204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185942138 | chr13:85862224-85862225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554277459 | chr13:85862260-85862261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572492862 | chr13:85862267-85862268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12877926 | chr13:85862269-85862270 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs561143923 | chr13:85862301-85862302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190810188 | chr13:85862303-85862304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576659040 | chr13:85862332-85862333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181765639 | chr13:85862348-85862349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562657623 | chr13:85862374-85862375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529957662 | chr13:85862375-85862376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565207934 | chr13:85862393-85862394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs377025933 | chr13:85862401-85862402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548459091 | chr13:85862406-85862407 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs199955583 | chr13:85862408-85862409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71210947 | chr13:85862409-85862410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186421749 | chr13:85862430-85862431 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142625991 | chr13:85862434-85862435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114865313 | chr13:85862435-85862436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1586653 | chr13:85862440-85862441 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs544432198 | chr13:85862456-85862457 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538312091 | chr13:85862469-85862470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12877297 | chr13:85862540-85862541 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs568599059 | chr13:85862572-85862573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2342394 | chr13:85862587-85862588 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs150973977 | chr13:85862599-85862600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191184866 | chr13:85862641-85862642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142071843 | chr13:85862642-85862643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145865975 | chr13:85862678-85862679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576534820 | chr13:85862683-85862684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138689305 | chr13:85862691-85862692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566453087 | chr13:85862726-85862727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376438359 | chr13:85862734-85862735 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141104852 | chr13:85862747-85862748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574573232 | chr13:85862787-85862788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1826142 | chr13:85862845-85862846 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs560462043 | chr13:85862870-85862871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75762461 | chr13:85862902-85862903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1602224 | chr13:85862971-85862972 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs531851764 | chr13:85862974-85862975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182967765 | chr13:85862993-85862994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538820469 | chr13:85863022-85863023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551157111 | chr13:85863031-85863032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568605341 | chr13:85863059-85863060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188472907 | chr13:85863085-85863086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547807173 | chr13:85863112-85863113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566045605 | chr13:85863160-85863161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191296413 | chr13:85863170-85863171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150278008 | chr13:85863190-85863191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85857000-85858200 | Enhancers | NH-A | brain |
2 | chr13:85857400-85858200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr13:85857400-85858200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr13:85862200-85862800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr13:85862200-85863600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr13:85862400-85863600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr13:85862600-85863000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr13:85862600-85863200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr13:85862800-85863000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr13:85862800-85863600 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr13:85862800-85863600 | Enhancers | HUES48 Cell Line | embryonic stem cell |